Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vildagliptin alleviates liver fibrosis in NASH diabetic rats via modulation of insulin resistance, oxidative stress, and inflammatory cascades
Ahmed S. Hendawy, Naglaa M. El-Lakkany, Eman M. Mantawy, et al.
Life Sciences (2022) Vol. 304, pp. 120695-120695
Closed Access | Times Cited: 19

Showing 19 citing articles:

Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology
Alba Sebastián-Martín, Belén G. Sánchez, José María Mora-Rodríguez, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2026-2026
Open Access | Times Cited: 31
Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies
Hao Chen, Yang Zhou, Haiping Hao, et al.
Chinese Journal of Natural Medicines (2024) Vol. 22, Iss. 8, pp. 724-745
Closed Access | Times Cited: 5
Inhibiting DPP4 activity protects hiPSC-derived steatotic HLCs by supporting fatty acid and purine metabolism and dampening inflammation
Christiane Lörch, Wasco Wruck, R. J. Julian, et al.
Research Square (Research Square) (2025)
Open Access
A Comparative Study of Nanoconjugates of a Synthetic and a Natural Drug Against T2DM-Induced Cognitive Dysfunction
Sweta Priyadarshini Pradhan, Anindita Behera, Pratap Kumar Sahu
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Closed Access
Pandanus Amaryllifolius Roxb. Polyphenol Extract Alleviates NAFLD via Regulating Gut Microbiota and AMPK/AKT/mTOR Signaling Pathway
Jinji Lin, Fei Ren, Mengxu Zhu, et al.
Foods (2025) Vol. 14, Iss. 6, pp. 1000-1000
Open Access
The antifibrotic effect of Vildagliptin and Diaminodiphenyl Sulfone in murine schistosomiasis mansoni
A.S. Amin H.A.M. Hendawy, Abdel-Nasser A. Sabra, Mina Y. George, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Vildagliptin attenuates doxorubicin-induced hepatotoxicity via activating Nrf2/HO-1 and SIRT1 and suppressing NF-κB signals in rats
Heba M. Mahmoud, Emad H.M. Hassanein, Marwa M. Khalaf
Immunopharmacology and Immunotoxicology (2025), pp. 1-11
Closed Access
Therapeutic potential and mechanism of Chinese herbal medicines in treating fibrotic liver disease
Yanwei Li, Yunrui LU, Mozuo NIAN, et al.
Chinese Journal of Natural Medicines (2023) Vol. 21, Iss. 9, pp. 643-657
Closed Access | Times Cited: 10
Management of type 2 diabetes in patients with compensated liver cirrhosis: Short of evidence, plenty of potential
Konstantinos Arvanitakis, Theocharis Koufakis, Georgios Kalopitas, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 18, Iss. 1, pp. 102935-102935
Closed Access | Times Cited: 9
Vildagliptin ameliorates intrapulmonary vasodilatation and angiogenesis in chronic common bile duct ligation-induced hepatopulmonary syndrome in rat
Safwat A. Mangoura, Marwa A Ahmed, Nashwa Hamad, et al.
Clinics and Research in Hepatology and Gastroenterology (2024) Vol. 48, Iss. 7, pp. 102408-102408
Closed Access | Times Cited: 3
Sangyod Rice Extract Mitigates Insulin Resistance in HepG2 cells and Hepatic Steatosis in Diabetic Rats via AMPK/mTOR/MAPK Signaling Pathways
Wanthanee Hanchang, Wanwipha Woonnoi, Jirawat Saetan, et al.
Food Bioscience (2024) Vol. 61, pp. 104662-104662
Closed Access | Times Cited: 3
RUNX1 promotes liver fibrosis progression through regulating TGF‐β signalling
Zhaoyang Guo, Xinxin Liu, Shulei Zhao, et al.
International Journal of Experimental Pathology (2023) Vol. 104, Iss. 4, pp. 188-198
Open Access | Times Cited: 7
Hepatoprotective effects of vildagliptin mitigates lung biochemical and histopathological changes in experimental hepatopulmonary syndrome model in rat
Safwat A. Mangoura, Marwa A Ahmed, Nashwa Hamad, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113254-113254
Closed Access | Times Cited: 2
Protective effects of Huang-Qi-Ge-Gen decoction against diabetic liver injury through regulating PI3K/AKT/Nrf2 pathway and metabolic profiling
Zhi‐Tong Zhang, Qingfeng Liang, Handong Wang, et al.
Journal of Ethnopharmacology (2023) Vol. 323, pp. 117647-117647
Closed Access | Times Cited: 6
Changes in Lipid Metabolism Enzymes in Rat Epididymal Fat after Chronic Central Leptin Infusion Are Related to Alterations in Inflammation and Insulin Signaling
María E. Casado, Sandra Canelles, E. Arilla, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7065-7065
Open Access | Times Cited: 5
Pathophysiological Features of Rat Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Y Saigo, Kinuko Uno, Tatsuya Ishigure, et al.
In Vivo (2024) Vol. 38, Iss. 3, pp. 990-999
Open Access | Times Cited: 1
How far are we from an approved drug for nonalcoholic steatohepatitis?
Nahúm Méndez‐Sánchez, Shreya C. Pal, Jacqueline Córdova‐Gallardo
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 9, pp. 1021-1038
Closed Access | Times Cited: 3
Inhibiting DPP4 activity protects hiPSC-derived steatotic HLCs by supporting fatty acid and purine metabolism and dampening inflammation
Christiane Loerch, Wasco Wruck, R. J. Julian, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
AN OVERVIEW OF INCRETIN-BASED THERAPIES: PHARMACOLOGY AND FUTURE PERSPECTIVES
Randa Ismail, Aliaa Anter, I. Matouk, et al.
Bulletin of Pharmaceutical Sciences Assiut (2022) Vol. 45, Iss. 2, pp. 1027-1042
Open Access
Page 1

Scroll to top